| HARRIS ASSOCIATES U.S. VALUE EQUITY H-I/A (EUR) | RVI USA VALOR | 4,11% | 34,12% | 32,47% | 168,12% |
| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) USD | RVI BIOTECNOLOGÍA | 81,98% | 91,84% | 63,35% | 168,11% |
| NORDEA 1-ASIA EX JAPAN EQUITY FUND AP-EUR | RVI ASIA EX-JAPÓN CRECIMIENTO | 56,59% | 65,42% | 33,41% | 168,11% |
| BARINGS GLOBAL EMERGING MARKETS FUND A USD CAP | RVI EMERGENTES | 59,63% | 81,07% | 57,18% | 168,10% |
| JPM GLOBAL NATURAL RESOURCES D (ACC) USD | RVI MATERIAS PRIMAS | 43,23% | 51,85% | 79,27% | 168,09% |
| MFS MERIDIAN U.S. CONCENTRATED GROWTH FUND C1-USD | RVI USA CRECIMIENTO | 6,82% | 20,42% | 25,30% | 168,08% |
| ROBECO BP US SELECT OPPORTUNITIES EQUITIES F USD | RVI USA SMALL/MID CAP | 19,61% | 43,69% | 56,86% | 168,07% |
| SCHRODER ISF EMERGING MARKETS B ACC USD | RVI EMERGENTES | 64,81% | 89,20% | 45,05% | 168,05% |
| SCHRODER ISF EUROPEAN VALUE I ACC EUR | RVI EUROPA VALOR | 24,73% | 62,34% | 90,36% | 168,02% |
| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) HKD | RVI BIOTECNOLOGÍA | 81,95% | 91,78% | 63,36% | 167,97% |
